Published in J Virol on November 01, 1984
Circularization of the herpes simplex virus type 1 genome upon lytic infection. J Virol (2005) 1.25
Inversion and circularization of the varicella-zoster virus genome. J Virol (1985) 1.17
Pathogenesis of Herpesvirus sylvilagus infection in cottontail rabbits. Am J Pathol (1988) 0.85
Herpesvirus sylvilagus infects both B and T lymphocytes in vivo. J Virol (1985) 0.84
Genome structure of cottontail rabbit herpesvirus. J Virol (1989) 0.79
Arrangement of repetitive sequences in the genome of herpesvirus Sylvilagus. J Virol (1989) 0.78
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
A rapid method for the identification of plasmid desoxyribonucleic acid in bacteria. Plasmid (1978) 26.51
Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components. Proc Natl Acad Sci U S A (1975) 10.59
Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J Virol (1984) 4.72
Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci U S A (1975) 3.26
Herpesvirus saimiri. II. Experimentally induced malignant lymphoma in primates. Lab Anim Care (1969) 3.06
Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. J Virol (1980) 2.69
Structure of nonintegrated, circular Herpesvirus saimiri and Herpesvirus ateles genomes in tumor cell lines and in vitro-transformed cells. J Virol (1982) 2.23
Episomal viral DNA in a Herpesvirus saimiri-transformed lymphoid cell line. J Virol (1977) 1.93
T lymphoblastoid cell lines from Marek's disease lymphomas. Nature (1974) 1.68
Herpesvirus ateles, a new lymphoma virus of monkeys. Nat New Biol (1972) 1.59
Purification and properties of Herpesvirus saimiri DNA. Virology (1974) 1.55
Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid. Virology (1976) 1.33
New member of the herpesvirus group isolated from wild cottontail rabbits. Infect Immun (1971) 1.32
Induction of lymphoid hyperplasia and lymphoma-like disease in rabbits by Herpesvirus sylvilagus. Int J Cancer (1971) 1.12
The densities of herpesviral DNAs. Prog Med Virol (1975) 1.10
Herpesvirus sylvilagus I. Polypeptides of virions and nucleocapsids. J Virol (1982) 0.97
Circular forms of viral DNA in Marek's disease virus-transformed lymphoblastoid cells. Arch Virol (1982) 0.91
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med (1995) 8.15
Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med (1989) 7.52
Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J Virol (1984) 4.72
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med (1996) 4.44
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med (2000) 4.12
Iron and the sex difference in heart disease risk. Lancet (1981) 3.45
High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol (1996) 2.61
Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood (1989) 2.37
Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med (1992) 2.33
Immune response after splenectomy. Lancet (1978) 2.31
Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J Virol (1984) 2.25
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. J Infect Dis (1998) 2.08
Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol (2000) 2.04
Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. J Virol (2000) 2.04
Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol (1998) 2.02
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis (1995) 1.97
Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera. J Virol (1989) 1.87
Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med (1975) 1.86
Influenza virus infection in nude mice. J Infect Dis (1976) 1.85
Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J Virol (2001) 1.80
Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. J Immunol (1989) 1.77
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res (1981) 1.72
Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants. J Immunol (2001) 1.72
HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J Immunol (1995) 1.69
Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N Engl J Med (1999) 1.69
Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature (1984) 1.63
Pharmacokinetics of nevirapine: initial single-rising-dose study in humans. Antimicrob Agents Chemother (1993) 1.62
Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol (1999) 1.61
Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. J Biol Chem (2000) 1.61
High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J Infect Dis (1995) 1.58
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med (1997) 1.56
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.55
Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants. J Virol (1999) 1.54
Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1. AIDS (1991) 1.53
Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses (1994) 1.51
Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection. N Engl J Med (1997) 1.50
"Chronic Epstein-Barr virus infection" syndrome and polymyalgia rheumatica. J Rheumatol (1988) 1.50
Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis (1986) 1.47
Inhibition of lymphocyte stimulation by measles virus. J Immunol (1975) 1.47
Antioxidants and coronary heart disease. Lancet (1991) 1.43
On the antioxidant properties of erythropoietin and its association with the oxidative-nitrosative stress response to hypoxia in humans. Acta Physiol (Oxf) (2014) 1.43
Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol (1987) 1.42
Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. J Infect Dis (1997) 1.41
Reactive histiocytic disorders. Am J Clin Pathol (1993) 1.41
Vertical transmission of Mycobacterium tuberculosis in KwaZulu Natal: impact of HIV-1 co-infection. Int J Tuberc Lung Dis (2004) 1.39
Racial/ethnic differences in HIV-1 seroprevalence and risky behaviors among intravenous drug users in a multisite study. Am J Epidemiol (1990) 1.38
Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection. J Immunol (2001) 1.37
In vitro immortalization of marmoset cells with three subgroups of herpesvirus saimiri. J Virol (1987) 1.36
Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis. N Engl J Med (1975) 1.36
IL-2 independent growth and cytotoxicity of herpesvirus saimiri-infected human CD8 cells and involvement of two open reading frame sequences of the virus. Virology (1993) 1.35
Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure. Pediatr Infect Dis J (2001) 1.34
Soluble CD8 during T cell activation. J Immunol (1989) 1.34
Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. J Pediatr (1991) 1.32
Frequency of 'chronic active Epstein-Barr virus infection' in a general medical practice. JAMA (1987) 1.31
Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. J Infect Dis (1991) 1.26
Deficient natural killer cell activity in x-linked lymphoproliferative syndrome. Science (1980) 1.25
Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients. Prog Clin Biol Res (1982) 1.24
Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis. J Infect Dis (1994) 1.23
Immunological bases for superior survival of females. Am J Dis Child (1979) 1.22
Adenosine deaminase activity in lymphocytes. Br J Haematol (1977) 1.21
Retinopathy of prematurity and iron: a modification of the oxygen hypothesis. Pediatrics (1986) 1.20
Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants. J Exp Med (1997) 1.19
The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line. Am J Pathol (1986) 1.18
Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants. Pediatr Infect Dis J (2001) 1.18
Pathogenesis of B cell lymphoma in a patient with AIDS. Blood (1986) 1.18
Murine natural killer cells stimulated in vivo do not express the T cell receptor alpha, beta, gamma, T3 delta, or T3 epsilon genes. J Immunol (1987) 1.18
Atypical depression. Arch Gen Psychiatry (1982) 1.18
Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection. J Infect Dis (1993) 1.16
Caffeine poisioning in an infant. J Pediatr (1977) 1.15
Myocarditis presenting as acute myocardial infarction. Am Heart J (1988) 1.14
Effect of HIV on thymic function before and after antiretroviral therapy in children. J Infect Dis (2000) 1.14
Resistance to apoptosis in HIV-infected CD4+ T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence. J Immunol (2000) 1.14
X-linked lymphoproliferative syndrome registry report. J Pediatr (1980) 1.13
Pharmacokinetics, safety, and activity of nevirapine in human immunodeficiency virus type 1-infected children. J Infect Dis (1996) 1.12
Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses. J Pediatr (1986) 1.11
Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am J Epidemiol (1976) 1.11
Immune responses during measles infection in immunosuppressed Rhesus monkeys. J Immunol (1977) 1.10
Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Blood (1985) 1.06
Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitution. J Infect Dis (1993) 1.04
Dyskinesias associated with tricyclic antidepressants. Br J Psychiatry (1976) 1.03
Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort. J Infect Dis (1999) 1.03
The changing face of pediatric HIV-1 infection. N Engl J Med (2001) 1.02
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies. Cancer Res (1981) 1.01
Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalities. J Pediatr (1987) 1.01
Inositol-less death in Neurospora and cellular ageing. Nat New Biol (1973) 1.01
Quantitation of human immunodeficiency virus in vertically infected infants and children. J Pediatr (1991) 0.99
Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrate. Am J Med (1986) 0.99
Detection of HIV-1-infected cells from patients using nonisotopic in situ hybridization. Blood (1989) 0.98
Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study. J Infect Dis (1997) 0.98
X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency. J Clin Invest (1983) 0.98
Epstein-Barr-virus induced lymphoproliferation. Implications for antiviral chemotherapy. N Engl J Med (1984) 0.97
Subcellular localization of low-abundance human immunodeficiency virus nucleic acid sequences visualized by fluorescence in situ hybridization. Proc Natl Acad Sci U S A (1990) 0.97
Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice. J Immunol (2000) 0.96
Acute epiglottitis. Review of 55 cases and suggested protocol. Arch Otolaryngol (1974) 0.96